UK OPSS calls for data on the safety of cosmetic ingredients
On 15 August 2023, the Office for Product Safety and Standards (OPSS – the UK regulator for cosmetic products) issued calls for data on the safety of cosmetic ingredients to investigate any suspected endocrine disrupting properties and safety whe used as nanomaterials.

On 15 August 2023, the UK Office for Product Safety and Standards (OPSS) launched two calls for data on cosmetic ingredients with suspected endocrine disrupting properties and cosmetic ingredients used as nanomaterials. 

Ingredients to be evaluated in cosmetic products due to their suspected endocrine disrupting properties:

  • Triclosan (CAS 3380-34-5)
  • Triclocarban (CAS 101-20-2)
  • 4-Methylbenzylidene camphor (4-MBC) (CAS 36861-47-9 / 38102-62-4)
  • Salicylic Acid (CAS 69-72-7)
  • Butylparaben (CAS 94-26-8)
  • Methylparaben (CAS 99-76-3)

The deadline for submission of data is 15 December 2023.

Nanomaterials to be safety assessed in cosmetic products:

  • Platinum
  • Copper
  • Silver
  • Gold, colloidal gold, gold thioethylamino hyaluronic acid
  • Silica, hydrated silica, silica silylate, silica dimethyl silylate
  • Lithium magnesium sodium silicate
  • Hydroxyapatite

The deadline for submission of data for silica, hydrated silica, silica silylate, and silica dimethyl silylate is 27 June 2025. For all other substances, the deadline is 22 December 2023.

References:

Office for Product Safety and Standards (OPSS) – Call for Data: Safety of Cosmetic Ingredients

other REGULATORY UPDATES

Regulation (EU) 2022/692 – OMNIBUS ACT VI – New and Updated Classification of Cosmetic Ingredients

Ingredients: BENZOPHENONE, TEOPHYLLINE, MELAMINE, AZADIRACHTA EXTRACTS, TRIMETHYLOLPROPANE TRIACRYLATE, PENTETIC ACID, PENTASODIUM PENTETATE

Date of publication: 03/05/2022

Date of application: 01/12/2023

The Commission Delegated Regulation (EU) 2022/692 includes new or updated classification for 12 chemicals that may be used as cosmetic ingredients. Seven out of these 12 are now classified as carcinogenic, mutagenic or toxic to reproduction (CMR) and are banned from cosmetic products marketed in the EU.

Read More »

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »
Any REGULATORY QUESTION?

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »

SCCS Revision of the Scientific Opinion on Vitamin A

Ingredients: RETINOL, RETINYL PALMITATE, RETINYL ACETATE, RETINYL LINOLEATE, RETINAL

Date of publication: 25/10/2022

The Scientific Committee on Consumer Safety has issued a final version of the Scientific Opinion on Vitamin A, concluding that exposure to Vitamin A derived from cosmetics can be a concern for higher exposure consumers, and since cosmetics alone do not exceed the upper limit the SCCS cannot suggest maximum concentration limits that take into account contributions from other sources.

Read More »

SCCS Preliminary Opinion on Sodium Bromothymol Blue (C186) as hair dyeing

Ingredients: SODIUM BROMOTHYMOL BLUE (C186)

Date of publication: 28/10/2022

Following the request from the EU Commission for a scientific opinion on the hair dye Sodium Bromothymol Blue (C186), on October 2022 the Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion. In light of the data provided, when used in non-oxidative hair colouring products up to a maximum on-head concentration of 0.5%, the SCCS is of the opinion that the complete safety of Sodium Bromothymol Blue could not be assessed.

Read More »